alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with sincalide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lanza, M; Makovec, F | 1 |
1 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and sincalide
| Article | Year |
|---|---|
Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cholecystokinin; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Interneurons; Male; Microdialysis; N-Methylaspartate; Nucleus Accumbens; Potassium; Quinoxalines; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Stimulation, Chemical; Tetrodotoxin | 2000 |